In early 2026, Artificial Intelligence (AI) has transitioned from a research tool to the primary engine for biomarker discovery. These "learning algorithms" are now capable of scanning billions of data points from electronic health records and biobanks to identify subtle "biomarker signatures" that were previously invisible to human researchers. The most exciting development is the rise of...